Akademska digitalna zbirka SLovenije - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov konzorcija SI. Za polni dostop se PRIJAVITE.

1 2 3
zadetkov: 26
1.
  • Low-Dose Decitabine Versus ... Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
    LÜBBERT, Michael; SUCIU, Stefan; BEELDENS, Filip ... Journal of clinical oncology, 05/2011, Letnik: 29, Številka: 15
    Journal Article
    Recenzirano
    Odprti dostop

    To compare low-dose decitabine to best supportive care (BSC) in higher-risk patients with myelodysplastic syndrome (MDS) age 60 years or older and ineligible for intensive chemotherapy. Two-hundred ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
2.
  • Daunorubicin Versus Mitoxan... Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
    MANDELLI, Franco; VIGNETTI, Marco; THOMAS, Xavier ... Journal of clinical oncology, 11/2009, Letnik: 27, Številka: 32
    Journal Article
    Recenzirano
    Odprti dostop

    To compare the antitumor efficacy of three different anthracyclines in combination with cytarabine and etoposide in adult patients with newly diagnosed acute myeloid leukemia (AML). We randomly ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK

PDF
3.
  • Treatment of childhood T-ce... Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial
    Uyttebroeck, Anne; Suciu, Stefan; Laureys, Geneviève ... European journal of cancer (1990), 04/2008, Letnik: 44, Številka: 6
    Journal Article
    Recenzirano

    Abstract From June 1989 through to November 1998, 121 children with newly diagnosed T-cell lymphoblastic lymphoma (T-LBL) were included in the EORTC 58881 trial conducted by the Children’s Leukaemia ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
4.
  • Improved outcome with pulse... Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951
    De Moerloose, Barbara; Suciu, Stefan; Bertrand, Yves ... Blood, 07/2010, Letnik: 116, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    The European Organisation for Research and Treatment of Cancer 58951 trial for children with acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL) addressed 3 randomized questions, ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
5.
  • Randomized trial of two sch... Randomized trial of two schedules of low‐dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML‐19)
    Amadori, Sergio; Suciu, Stefan; Selleslag, Dominik ... British journal of haematology, 20/May , Letnik: 149, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    Summary This study compared two schedules of low‐dose gemtuzumab ozogamicin (GO) as induction monotherapy for untreated acute myeloid leukaemia in older patients unfit for intensive chemotherapy, to ...
Celotno besedilo
Dostopno za: BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK

PDF
6.
  • Second neoplasm in children... Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: Low incidence of CNS tumours
    Renard, Marleen; Suciu, Stefan; Bertrand, Yves ... Pediatric blood & cancer, 15 July 2011, Letnik: 57, Številka: 1
    Journal Article
    Recenzirano

    Background Intensive chemotherapy has markedly improved the survival of children with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LL). Evaluation of late effects and analysis of ...
Celotno besedilo
Dostopno za: BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
7.
  • Adjuvant regional chemother... Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II–III colorectal cancer: a multicentre randomised controlled phase III trial
    Nordlinger, Bernard; Rougier, Philippe; Arnaud, Jean-Pierre ... The lancet oncology, 07/2005, Letnik: 6, Številka: 7
    Journal Article
    Recenzirano

    Systemic adjuvant chemotherapy can improve overall survival and reduce the incidence of distant metastases for patients with advanced colon cancer. This study aimed to investigate whether regional ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
8.
Celotno besedilo
Dostopno za: BFBNIB, DOBA, FZAB, GIS, IJS, IZUM, KILJ, NLZOH, NUK, OILJ, PILJ, PNG, SAZU, SBCE, SBMB, SIK, UILJ, UKNU, UL, UM, UPUK
9.
  • Gem-(R)CHOP Versus (R)CHOP:... Gem-(R)CHOP Versus (R)CHOP: A Randomized Phase II Study of Gemcitabine Combined with (R)CHOP in Untreated Aggressive Non- Hodgkin's Lymphoma - EORTC Lymphoma Group Protocol 20021
    Aurer, Igor; Eghbali, Houchingue; Raemaekers, John M. ... Blood, 11/2008, Letnik: 112, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Despite recent advances many patients with aggressive NHL succumb to their disease and improvements in front-line chemotherapy are still needed. Gemcitabine is active in lymphoma. We embarked on a ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP
10.
  • Gem-(R)CHOP versus (R)CHOP:... Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma - EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)
    Aurer, Igor; Eghbali, Houchingue; Raemaekers, John ... European journal of haematology, 02/2011, Letnik: 86, Številka: 2
    Journal Article
    Recenzirano

    Background:  Despite recent improvements, many patients with aggressive non‐Hodgkin’s lymphoma (NHL) ultimately succumb to their disease. Therefore, improvements in front‐line chemotherapy of ...
Celotno besedilo
Dostopno za: BFBNIB, DOBA, FZAB, GIS, IJS, IZUM, KILJ, NLZOH, NUK, OILJ, PILJ, PNG, SAZU, SBCE, SBMB, SIK, UILJ, UKNU, UL, UM, UPUK
1 2 3
zadetkov: 26

Nalaganje filtrov